-
Uncategorized2 weeks ago
FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of new approach methodologies, experts told...
-
Endpoints News2 weeks ago
Q&A: Controversial embryo editing entrepreneur Cathy Tie on her new startup
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening...
-
BioPharma Dive – AI / Data2 weeks ago
Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases
Acquiring Ouro Medicines, which launched last year, hands Gilead an antibody designed to bind to BCMA and CD3, a pair of immune cell proteins that are...
-
STAT News – Biotech2 weeks agoSTAT+: Can you spot a deepfake X-ray? Neither can your radiologist
Deepfake images can mislead viewers, upend elections, and instigate violence. They can also, researchers say, disrupt medical care. In a study published Tuesday in Radiology, an...
-
BioPharma Dive – AI / Data2 weeks agoImmutrin raises $87M to advance drug for progressive heart disease
The fresh funding will help the biotech startup advance a candidate to treat a genetic disorder, “ATTR-CM,” that has become a battleground for companies like Pfizer,...
-
BioPharma Dive – AI / Data2 weeks agoKaryopharm myeloma drug yields mixed data in myelofibrosis trial
Xpovio combined with Incyte’s Jakafi helped on one key measure but missed on other goal in a disorder that, by one analyst’s estimates, could triple the...
-
STAT News – Biotech2 weeks agoSTAT+: Buzzy AI doctor startup raises funds, will meet FDA
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
STAT News – Biotech2 weeks agoSTAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Good morning. I’ve been seeing posts everywhere about a group of dogs, led by a corgi, that reportedly escaped captivity and traveled across highways to get...
-
STAT News – Biotech2 weeks agoSTAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the blustery Pharmalot campus,...
-
STAT News – Biotech2 weeks agoAre we underestimating alcohol-related liver disease?
Good morning. With so much snow this winter, I gave up on biking to the office for a while. I’m happy to be back at it...
